Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,586,000 | 1,656,000 | 5,776,000 | 5,033,000 | 7,683,000 |
| Marketable Securities | 939,000 | 1,173,000 | 2,957,000 | 2,268,000 | 831,000 |
| Receivables | 3,360,000 | 3,083,000 | 3,743,000 | 3,480,000 | 3,164,000 |
| Inventories | 1,498,000 | 1,657,000 | 1,384,000 | 1,204,000 | 1,413,000 |
| Income taxes - deferred | 1,701,000 | 1,597,000 | 1,200,000 | 1,036,000 | 611,000 |
| Other current assets | 7,420,000 | 0 | 0 | 0 | 0 |
| TOTAL | $18,916,000 | $9,521,000 | $15,318,000 | $13,273,000 | $13,958,000 |
| Non-Current Assets | |||||
| PPE Net | 4,579,000 | 5,333,000 | 4,521,000 | 4,664,000 | 5,055,000 |
| Investments And Advances | 3,747,000 | 3,523,000 | 2,909,000 | 2,681,000 | 1,369,000 |
| Intangibles | 9,414,000 | 16,413,000 | 8,710,000 | 8,603,000 | 8,083,000 |
| Other Non-Current Assets | 1,936,000 | 1,107,000 | 1,512,000 | 1,855,000 | 2,543,000 |
| TOTAL | $19,676,000 | $26,376,000 | $17,652,000 | $17,803,000 | $17,050,000 |
| Total Assets | $38,592,000 | $35,897,000 | $32,970,000 | $31,076,000 | $31,008,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 359,000 | 826,000 | 115,000 | 117,000 | 231,000 |
| Accounts payable and accrued liabilities | 2,559,000 | 2,202,000 | 2,603,000 | 1,983,000 | 1,711,000 |
| Accrued Expenses | 2,152,000 | 2,573,000 | 2,791,000 | 2,740,000 | 2,785,000 |
| Other current liabilities | 4,931,000 | N/A | N/A | N/A | N/A |
| TOTAL | $12,440,000 | $8,279,000 | $7,780,000 | $6,739,000 | $6,313,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,981,000 | 6,568,000 | 5,376,000 | 5,328,000 | 6,130,000 |
| Deferred Revenues | 756,000 | 825,000 | 337,000 | 402,000 | 237,000 |
| aiOther Non-Current Liabilities | 1,326,000 | 1,816,000 | 850,000 | 310,000 | 830,000 |
| TOTAL | $10,916,000 | $13,980,000 | $9,323,000 | $8,699,000 | $9,910,000 |
| Total Liabilities | $23,356,000 | $22,259,000 | $17,103,000 | $15,438,000 | $16,223,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,650,233 | 1,637,355 | 1,688,107 | 1,702,427 | 1,714,141 |
| Common Shares | 221,000 | 221,000 | 220,000 | 220,000 | 220,000 |
| Retained earnings | 32,952,000 | 32,733,000 | 33,069,000 | 31,636,000 | 30,760,000 |
| Other shareholders' equity | -2,059,000 | -3,187,000 | -3,134,000 | -2,446,000 | -2,599,000 |
| TOTAL | $15,236,000 | $13,638,000 | $15,867,000 | $15,638,000 | $14,785,000 |
| Total Liabilities And Equity | $38,592,000 | $35,897,000 | $32,970,000 | $31,076,000 | $31,008,000 |